Editorial: Current status and recent advances in preclinical models for rare cancers
Saved in:
| Main Authors: | Ewa Krawczyk, Luciane R. Cavalli, Joanna Kitlinska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1676020/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Curcumin as a therapeutic agent in liver cancer: a systematic review of preclinical models and mechanisms
by: Ke Ma, et al.
Published: (2025-07-01) -
Methods for Preclinical Assessment of the Efficacy of Anticancer Medicines <i>in vivo</i> (Review)
by: M. L. Vasyutina, et al.
Published: (2025-07-01) -
Insights from in vivo preclinical cancer studies with histotripsy
by: Tejaswi Worlikar, et al.
Published: (2024-12-01) -
The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy
by: Abdo Meyiah, et al.
Published: (2025-03-01) -
Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies
by: Zane Kalniņa, et al.
Published: (2025-08-01)